benefits of glp-1 agonists Frontiers In patients with #obesity, incretin-based
Description
New trends in adverse respiratory events from ASA Closed Claims Project
doi: 10.1016/S0140-6736(09)61375-1 90 LeanMEJCarraroRFinerNHartvigHLindegaardMLRssnerSet al
J., Imbens, G
Furthermore, GLP-1 receptor agonists induce anti-inflammatory effects that could attenuate the low-grade inflammation that underlies obesity, PsO, and HS (reviewed recently in the context of PsO and psoriatic arthritis).68 Finally, improved metabolic control and cardio-renal protection could be beneficial for reducing CVR and managing comorbidities such as DT2 or metabolic syndrome
Some plans may require documentation of BMI, comorbidities, and previous supervised weight-loss attempts
Weight loss with tirzepatide 15 mg was 11.2 kg compared to 5.7 kg with semaglutide, nearly double
